Understanding how psychological factors affect growth after cancer treatment
Study of the Psychological Factors Influencing Post-traumatic Growth During Oncological Pathway
This study is testing how emotional skills and flexibility can help cancer patients grow and feel better after their first treatment for solid tumors.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 289 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Centre Hospitalier de Valenciennes Research network |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Valenciennes) |
| Trial ID | NCT06278558 on ClinicalTrials.gov |
What this trial studies
This study investigates the role of psychological factors, such as emotional competence and psychological flexibility, in promoting post-traumatic growth among cancer patients. It focuses on individuals undergoing their first curative treatment for solid tumors, assessing their psychological state and care satisfaction at the beginning of their treatment. The study will track changes in these psychological variables and their impact on personal growth at the end of chemotherapy and six months later. Participants will engage in interviews with psychologists or psychiatrists to gather data on their experiences.
Who should consider this trial
Good fit: Ideal candidates are adults over 18 years old who are starting their first curative treatment for a solid cancer and are within six months of their initial diagnosis.
Not a fit: Patients with a history of cancer, those with incurable disease progression, or those unable to understand the study's requirements may not benefit.
Why it matters
Potential benefit: If successful, this study could help identify psychological factors that enhance recovery and personal growth in cancer patients.
How similar studies have performed: While the specific approach of this study may be novel, previous research has indicated that psychological factors can significantly influence recovery and growth in cancer patients.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients over 18 years of age * Patients in the initial phase of curative treatment for a 1st solid cancer * At the start of neo-adjuvant or adjuvant chemotherapy (1st course or 2nd course) * At less than 6 months from the initial diagnosis * Patient having given written consent to participate in the study Exclusion Criteria: * Patients with a previous history of cancer * Patients with incurable cancer progression, recurrence or relapse * Metastatic, brain, hematological or skin cancer * Patients who have difficulty understanding written French * Patient psychologically or physically unable to answer questionnaires
Where this trial is running
Valenciennes
- Centre Hospitalier de Valenciennes — Valenciennes, France (Recruiting)
Study contacts
- Principal investigator: Anne-Sophie Baudry — CH de Valenciennes
- Study coordinator: Anne-Sophie Baudry
- Email: baudry-as@ch-valenciennes.fr
- Phone: 0327140523
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.